Most cosmetic peptides have one or two well-characterized mechanisms
Circulation 148 , 16061635 (2023)
Retatrutide , developed by Eli Lilly, is a novel triple agonist that simultaneously activates three receptors: GLP-1 (glucagon-like peptide-1) receptor reduces appetite and slows gastric emptying GIP (glucose-dependent insulinotropic polypeptide) receptor enhances insulin secretion
RNK06395 degraded the ERK5 protein in several cell lines, including Huh-7 (Dmax of 71.3% with a DC 50 of 50.98 nM), MOLP-8 (Dmax of 84.7% with a DC 50 of 24.54 nM), and A427 (Dmax of 55.9% with a DC 50 of 186.8) (Fig
Ingredients: Purified Water, Coconut Oil, Sodium Hydroxide, Glutathione, Kojic Acid, Placenta, Titanium Dioxide, Iron Oxide No Hydroquinone, no mercury or harsh chemicals